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 The EuPA Standardization Initiative
Mass spectrometry has experienced huge advances in the last 
decade increasing the coverage, accuracy and capacity of pro-
tein/peptide measurements in complex biological samples. 
The ability to massively identify and quantify proteins places 
proteomics as one of the most valuable analytical resources 
to such measurements, leading to a better understanding of 
sophisticated cellular processes at the functional level. To 
increase accuracy and enable inter- and intra-laboratory ex-
perimental comparisons, reliability, robustness and reproduc-
ibility must be possible and embedded in the technology. To 
this end, it is critical to defi ne quality control procedures and 
standardized protocols for the whole proteomics workfl ow, 
from sample collection and preparation to data collection and 
computational analysis and fi nally data exchange. 
The EuPA Standardization initiative (Figure 1) is of utmost 
importance since standardization of proteomics workfl ows 
will promote the consolidation of a common space, integrat-
ing proteomic strengths across Europe, based on the easy 
exchange of information generated according to normalized 
protocols based on standardized data formats. Besides im-
proving the effi ciency within the proteomics environment, 
standardization is crucial to increase the impact and rele-
vance of proteomics in other scientifi c disciplines. It is impor-
tant to note that the translation of analytical results into rel-
evant biological knowledge and practical applications is often 
hampered by the lack of standardized protocols that emerge, 
therefore, as an urgent need. 
The overall aim of this initiative is the organization of multi-
laboratory studies to:
• Evaluate protocols, protocol variants, workfl ows and 
data processing procedures to assess reproducibility, 
robustness and technical limits. Optimization of ex-
isting protocols. Interaction with potential industrial 
partners; the collaboration with SIGMA has been re-
markable in previous standardization initiatives and 
their participation has been already agreed. (Other ef-
forts to strengthen our initiatives are welcome).
• Deliver protocols of common proteomics procedures 
under standardized conditions. Defi nition of standard 
operation procedures (SOPs), limit of detection (LOD), 
limit of quantifi cation (LOQ). Ensure open access and 
communication with existing and ongoing HUPO-PSI. 
Easy exchange of technology and results across labo-
ratories. 
• Facilitate the implementation of standardized proto-
cols in current and emergent facilities with limited 
experience and scope. Methods for self-performance 
evaluation. 
Milestones
• Annual strategic discussions to defi ne the study. 
• Reference sample preparation.
• Call for participants via EuPA network.
• Sample distribution.
• Analysis of the results.
• Meeting for presentation and discussion of the results. 
• Creation of a repository of standardized protocols 
publicly accessible from the EuPA web page.
Deliverables
• Study proposal. Description, guidelines and recom-
mendations. Publication on the EuPA web page [www.
eupa.org].
• Intermediate report and congress submission.
• Publication of the results and main conclusions. 
• Standardized protocol posted on the EuPA web page.
Figure 1. Launching of the EuPA Standardization Initiative.
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